Skip to content

CARD for Community Pharmacy Vaccinations

CARD (Comfort Ask Relax Distract) for Community-based Pharmacy Vaccinations

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06098703
Enrollment
2000
Registered
2023-10-24
Start date
2023-11-01
Completion date
2024-12-31
Last updated
2023-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community Pharmacy, Vaccination Pain, Vaccination Reaction

Keywords

Vaccination reaction, Vaccination experience

Brief summary

To integrate CARD in community pharmacy-led vaccinations and document impact on vaccine clients and pharmacy staff.

Detailed description

It is estimated that 1 out of 5 children and adults are not vaccinated because of concerns about pain and fear. The CARD (Comfort Ask Relax Distract) system is a new vaccine delivery system proven to reduce pain, fear and immunization stress-related responses. Improving the vaccination experiences of patients can improve attitudes about vaccination and increase vaccine acceptance. The objective of this cluster randomized trial is to evaluate scaling of CARD across community pharmacies on patients vaccination symptoms, beliefs and attitudes and pharmacy staff beliefs and attitudes.

Interventions

BEHAVIORALCARD (Comfort Ask Relax Distract)

CARD is a vaccine delivery framework/protocol to plan and deliver vaccinations

Sponsors

Public Health Agency of Canada (PHAC)
CollaboratorOTHER_GOV
Wholehealth Pharmacy Partners
CollaboratorUNKNOWN
University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Vaccine recipients will not be aware of whether they are in the intervention or control group or the objective of the trial. Care providers who are trained in the intervention are aware of the group allocation. They will not communicate with care providers not trained in the intervention. Care providers that are in the intervention pharmacies will not deliver care to participants in the control pharmacies and care providers in the control pharmacies will not deliver care in the intervention pharmacies. Vaccine recipients are rating the primary outcome.

Intervention model description

Cluster trial involving at least 24 community pharmacies allocated to CARD or control (standard care) in a 1:1 ratio. Eligible pharmacies belonging to Wholehealth Pharmacy Partners from across Ontario, Canada, will be included.

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* vaccine clients being vaccinated in community pharmacies participating in the project * pharmacy staff in community pharmacies participating in the project

Exclusion criteria

* unable to understand and read English

Design outcomes

Primary

MeasureTime frameDescription
Experience with vaccinationwithin 15 minutes after vaccinationVaccine client self-reported experience with vaccination (better or not)

Secondary

MeasureTime frameDescription
Painwithin 15 minutes after vaccinationVaccine client self-reported pain during vaccination (0-10)
Dizzinesswithin 15 minutes after vaccinationVaccine client self-reported dizziness during vaccination (0-10)
Faintingwithin 15 minutes after vaccinationFainting during/after vaccination (yes/no)
Utilization of coping strategies during vaccinationwithin 5 minutes of vaccinationUse of individual coping strategies during vaccination (e.g., distraction, support person) (yes/no)
Fearwithin 15 minutes after vaccinationVaccine client self-reported fear during vaccination (0-10)
Implementation success of CARDwithin 3 months of vaccination clinicsPerceptions of implementation success of CARD program delivery as reported by CARD implementers (primary targets) using CARD Global Impression Checklist, individual questions (5-point Likert Scale higher number represents better outcome); responses reported for individual items. This information is supplemented with focus group information and study notes.
Attitudes about vaccinationwithin 3 months of vaccination clinicsPerceptions of CARD and non-CARD implementers using CARD Attitudes survey, individual questions (5-point Likert Scale higher number represents better outcome); responses reported for individual items. This information is supplemented with focus group information and study notes.
Vaccination behaviourswithin 3 months of vaccination clinicsSelf-reported vaccine behaviours of immunizers using CARD Behaviour Survey, individual questions (rank as whether behaviours are done or not); responses reported for individual items. Includes CARD and non-CARD implementers.
Vaccine interaction surveywithin 5 minutes of vaccinationPerceptions of CARD and non-CARD immunizers about vaccination interaction \[duration, satisfaction, CARD usefulness (intervention group only)\]; responses reported for individual items.
CARD satisfaction surveywithin 15 minutes of vaccinationVaccine client self-reported satisfaction with CARD (e.g., helpfulness, willingness to use again, willingness to return for next vaccination, vaccination decision-making, as applicable), responses reported for individual items

Countries

Canada

Contacts

Primary ContactCharlotte Logeman, MPH
charlotte.logeman@utoronto.ca416-978-2889
Backup ContactVictoria Gudzak, MSc
victoria.gudzak@mail.utoronto.ca416-978-2889

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026